Brief: Hepion Pharmaceuticals Announces Reverse Stock Split
10/05/2023 18:24
May 10 (Reuters) - Hepion Pharmaceuticals Inc HEPA.O :
* HEPION PHARMACEUTICALS, INC. ANNOUNCES REVERSE STOCK SPLIT
* HEPION PHARMACEUTICALS - WILL EFFECT REVERSE STOCK SPLIT
OF ITS
OUTSTANDING SHARES OF COMMON STOCK AT A RATIO OF 1-FOR-20,
EFFECTIVE AS OF MAY 10
* HEPION PHARMACEUTICALS - COMMON STOCK WILL BEGIN TRADING
ON
SPLIT-ADJUSTED BASIS WHEN MARKET OPENS ON MAY 11 UNDER EXISTING
TRADING SYMBOL "HEPA."
Source text for Eikon: ID:nGNX9zNr1n
Further company coverage: HEPA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hepion Pharmaceuticals
See all newsBrief: Hepion Pharmaceuticals Executes Binding Letter Of Intent With New Day Diagnostics To Commercialize Diagnostic Tests For Celiac Disease, Respiratory Multiplex, H. Pylori And Hcc
Brief: Hepion Pharma In-Licenses Diagnostic Tests from New Day Diagnostics- SEC Filing
Brief: Hepion Pharmaceuticals Announces Termination Of Merger Agreement With Pharma Two B
Brief: Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B
Brief: Pharma Two B Plans To Go Public Via Merger With Hepion Pharmaceuticals, Concurrent $11.5 Mln Private Placement